Banco Santander’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15M | Buy |
117,047
+1,519
| +1% | +$178K | 0.09% | 138 |
|
|
2026
Q1 | $13.9M | Buy |
115,528
+1,404
| +1% | +$162K | 0.11% | 130 |
|
|
2025
Q4 | $12M | Sell |
114,124
-40,944
| -26% | -$3.84M | 0.09% | 133 |
|
|
2025
Q3 | $13M | Sell |
155,068
-216,463
| -58% | -$17.8M | 0.12% | 124 |
|
|
2025
Q2 | $29.4M | Buy |
371,531
+54,618
| +17% | +$4.34M | 0.28% | 58 |
|
|
2025
Q1 | $28.4M | Sell |
316,913
-190,114
| -37% | -$17.8M | 0.31% | 52 |
|
|
2024
Q4 | $50.4M | Buy |
507,027
+11,470
| +2% | +$1.18M | 0.61% | 27 |
|
|
2024
Q3 | $56.3M | Sell |
495,557
-4,817
| -1% | -$572K | 0.66% | 21 |
|
|
2024
Q2 | $61.9M | Buy |
500,374
+36,176
| +8% | +$4.66M | 0.77% | 19 |
|
|
2024
Q1 | $61.3M | Buy |
464,198
+134,522
| +41% | +$16.6M | 0.74% | 16 |
|
|
2023
Q4 | $35.9M | Buy |
329,676
+31,014
| +10% | +$3.22M | 0.42% | 33 |
|
|
2023
Q3 | $30.7M | Sell |
298,662
-1,758
| -0.6% | -$189K | 0.44% | 31 |
|
|
2023
Q2 | $34.7M | Buy |
300,420
+9,809
| +3% | +$1.11M | 0.45% | 25 |
|
|
2023
Q1 | $30.9M | Buy |
290,611
+6,051
| +2% | +$653K | 0.46% | 25 |
|
|
2022
Q4 | $31.6M | Sell |
284,560
-270,646
| -49% | -$27.7M | 0.47% | 24 |
|
|
2022
Q3 | $47.8M | Buy |
555,206
+19,420
| +4% | +$1.73M | 0.64% | 15 |
|
|
2022
Q2 | $48.8M | Buy |
535,786
+11,097
| +2% | +$984K | 0.65% | 19 |
|
|
2022
Q1 | $43M | Sell |
524,689
-28,319
| -5% | -$2.23M | 0.46% | 29 |
|
|
2021
Q4 | $42.4M | Buy |
553,008
+38,259
| +7% | +$3.05M | 0.23% | 31 |
|
|
2021
Q3 | $38.7M | Buy |
514,749
+47,879
| +10% | +$3.64M | 0.21% | 33 |
|
|
2021
Q2 | $36.3M | Buy |
466,870
+141,679
| +44% | +$10.5M | 0.2% | 28 |
|
|
2021
Q1 | $23.9M | Buy |
325,191
+5,236
| +2% | +$386K | 0.17% | 41 |
|
|
2020
Q4 | $25M | Buy |
319,955
+26,336
| +9% | +$2.01M | 0.18% | 33 |
|
|
2020
Q3 | $23.2M | Buy |
293,619
+7,479
| +3% | +$586K | 0.31% | 28 |
|
|
2020
Q2 | $21.1M | Buy |
286,140
+1,485
| +0.5% | +$112K | 0.27% | 29 |
|
|
2020
Q1 | $20.9M | Buy |
284,655
+29,091
| +11% | +$2.29M | 0.24% | 64 |
|
|
2019
Q4 | $22.2M | Buy |
255,564
+1,699
| +0.7% | +$140K | 0.2% | 53 |
|
|
2019
Q3 | $20.4M | Sell |
253,865
-77,793
| -23% | -$6.23M | 0.2% | 50 |
|
|
2019
Q2 | $26.5M | Buy |
331,658
+24,973
| +8% | +$1.91M | 0.27% | 36 |
|
|
2019
Q1 | $24.3M | Sell |
306,685
-49,683
| -14% | -$3.72M | 0.27% | 39 |
|
|
2018
Q4 | $26M | Buy |
356,368
+11,178
| +3% | +$789K | 0.33% | 38 |
|
|
2018
Q3 | $23.4M | Sell |
345,190
-36,671
| -10% | -$2.34M | 0.27% | 45 |
|
|
2018
Q2 | $22.1M | Sell |
381,861
-44,496
| -10% | -$2.51M | 0.26% | 51 |
|
|
2018
Q1 | $22.2M | Buy |
426,357
+278,514
| +188% | +$15M | 0.26% | 63 |
|
|
2017
Q4 | $7.94M | Buy |
147,843
+7,293
| +5% | +$404K | 0.11% | 74 |
|
|
2017
Q3 | $8.58M | Sell |
140,550
-2,823
| -2% | -$171K | 0.14% | 78 |
|
|
2017
Q2 | $8.78M | Sell |
143,373
-117,792
| -45% | -$7.17M | 0.17% | 60 |
|
|
2017
Q1 | $15.8M | Buy |
261,165
+61,042
| +31% | +$3.7M | 0.41% | 22 |
|
|
2016
Q4 | $10.8M | Buy |
+200,123
| New | +$11.7M | 0.28% | 28 |
|
Other funds holding MRK
ECSS
ATO
Banco Santander's MRK Position: Q2 2026 in Review
Banco Santander increased its Merck (MRK) stake by 1.3% in Q2 2026, buying an estimated $178K and bringing the position to 117,047 shares worth $15M. The position accounts for 0.09% of the portfolio, ranked #138.
Banco Santander first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. The position peaked at $61.9M in Q2 2024. 1,583 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Banco Santander held 117,047 shares of Merck worth $15M as of Q2 2026.
- Banco Santander bought 1,519 Merck shares in Q2 2026, an estimated $178K.
- Merck made up 0.09% of Banco Santander's portfolio in Q2 2026, its #138 holding.
- Banco Santander first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- Banco Santander's Merck position peaked at $61.9M in Q2 2024.
- 1,583 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.